The University of Washington is the first place to replicate the ECHO model outside of New Mexico. This innovative telehealth program helps clinicians serving in rural and underserved areas with the evaluation and treatment of hepatitis C and has since expanded into the areas of HIV/AIDS, chronic pain, addictions and psychiatry, multiple sclerosis and complex care. Project ECHO uses case-based learning to increase the capacity of primary care clinicians to care for common, complex diseases. Treatment of patients with hepatitis C through Project ECHO is as safe and effective as in person care (Arora S, et al. NEJM 2011) and is cost-effective. The Project ECHO model has spread throughout the United States.
Presented by: John Scott, MD, MSc is an Associate Professor of Medicine (Division of Allergy and Infectious Diseases) and the first Medical Director of Telehealth at the University of Washington. He graduated from Stanford University with a degree in Human Biology, attended Georgetown University School of Medicine cum laude, completed a residency in Internal Medicine at Stanford University Hospitals, and then obtained sub-specialty training in Infectious Diseases at the University of Washington. He has an active research program in viral hepatitis, which is supported by federal, foundation and pharmaceutical grants. He has published in JAMA, Hepatology, Clinical Infectious Diseases, Annals of Internal Medicine, Nature Medicine and the Journal of Infectious Diseases.
This website is supported by grant number G22RH31114 from the Office for the Advancement of Telehealth, Federal Office of Rural Health Policy, Health Resources and Services Administration, Department of Health and Human Services.